67.46USD-2.69%Mkt Cap: 13.42B $P/E: 187.38Today
BioMarin Pharmaceutical Inc., a biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, …
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$12.87BUSDP/E 264.5
$12.59BUSD
$12.48BUSD
Key Statistics
Company
Market Cap13.42B $
Enterprise Value16.43B $
Revenue (TTM)3.41B $
Gross Profit2.50B $
Net Income (TTM)348.90M $
Revenue/Share17.69 USD
Last Price67.46 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees3.2K
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS09061G1013
Valuation
P/E (Trailing)187.38
P/E (Forward)10.46
PEG0.54
EV/EBITDA25.46
EV/Revenue4.82
P/S3.85
P/B2.07
EPS (TTM)0.36
EPS (Forward)6.47
52W Range
49.2684% of range70.98
52W High70.98 USD
52W Low49.26 USD
Profitability
Gross Margin77.73%
Oper. Margin21.16%
EBITDA Margin18.94%
Profit Margin10.83%
ROE5.73%
ROA4.59%
Growth
Revenue Growth19.90%
Earnings Growth-81.30%
Cash Flow & Leverage
Operating CF827.99M $
CapEx (TTM)110.97M $
FCF Margin2.50%
FCF Yield0.63%
Net Debt3.33B $
Net Debt/EBITDA5.16
Balance Sheet
Debt/Equity0.10
Current Ratio2.39
Quick Ratio1.16
Book Value/Sh32.66 USD
Cash/Share4.515 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.7 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)91.04 USD
Upside (mean)+34.9%
Target Range59.00 USD – 124.00 USD
$59.00+34.9% to mean$124.00
# Analysts26
Ownership
Shares Out.193.57M
Float192.39M
Insiders0.34%
Institutions103.69%
Short Interest
Short Ratio7.9d
Short % Float6.48%
Short % Out.6.46%
Shares Short12.50M
Short (prev mo.)13.91M
Technical
SMA 5060.41 (+11.7%)
SMA 20057.17 (+18.0%)
Beta0.23
S&P 52W Chg18.16%
Avg Vol (30d)1.90M
Avg Vol (10d)2.74M
Technical Indicators
RSI (14)68.9
MACD2.6757
MACD Signal2.1786
MACD Hist.+0.4970
BB Upper71.76 USD
BB Middle63.37 USD
BB Lower54.98 USD
BB Width26.48%
ATR (14)2.060 USD
Vol Ratio (20d)0.88x